Interleukin 10 (IL10) is associated with maternal immunotolerance. IL10 also down-regulates decidual cell tissue factor expression, the main molecule triggering coagulation activation: this antithrombotic effect may protect the umbilicoplacental vasculature from the 10th wk of gestation onward. IL10 downregulation may thus dispose to early pregnancy loss (PL) due to maternal immunotolerance defect or late pregnancy failure due to placental vascular insufficiency. IL10 gene promoter polymorphisms associated with cytokine down-regulation may help to identify the actual and probable mechanisms of IL10 modulation in pregnancy outcomes. We investigated the following four IL10 promoter polymorphisms associated with IL10 down-regulation: two single-nucleotide polymorphisms rs1800871 and rs1800872 and two polymorphic CA repeat microsatellites IL10 X78437.2:g8134CA(14_29) and IL10 X78437.2:g.5325CA(11_15). Each microsatellite was analyzed as a biallelic polymorphism. Based on a review of the literature, we define a short allele and a long allele for each microsatellite. We compared their frequencies in early PL occurring before 10 wk of amenorrhea (n ¼ 342) and in PL occurring later on (n ¼ 123). The mutated alleles rs1800871T (odds ratio, 3.083; 95% confidence interval, 1.984-4.792) and rs1800872A (odds ratio, 3.013; 95% confidence interval, 1.924-4.719) were associated with early PL. The haplotype rs1800872A/rs1800871T/ X78437.2:g.8134CA[14_25]/X78437.2:g.5325CA[11_13], which includes the two mutated alleles, was significantly associated with the risk of early PL in a dose-dependent manner. Positivity for one haplotype was significantly associated with a 5.6-fold increase in the risk of early pregnancy failure, and positivity for two haplotypes was associated with an 8-fold increase in risk. In women with PL, some polymorphisms of the IL10 gene promoter seem to be constitutional risk factors for early (embryonic) pregnancy failure.
INTRODUCTION
Spontaneous abortions are common medical events and may account during the first trimester for one fifth of all intended pregnancies [1] . The mechanisms mediating the survival of the embryo/fetus and those leading to pregnancy loss (PL) are far from understood. Underlying maternal genetics and endocrine, anatomical, and autoimmune disorders are known causes, found in approximately 60% of cases of PL, with the remaining 40% being ''unexplained'' [2] . It has been suggested that these unexplained early PLs could be due to immunologic factors [3] . Data from rodent studies have shown that the major mechanism of immune-mediated early pregnancy failure is immune activation at the maternofetal interface [3] . Activation of decidual immune cells, with attendant inflammatory cytokine production, is thought to directly damage the embryo/fetus and the placenta. Successful pregnancy has been proposed to be a T helper (Th) 2-type phenomenon, with Th1-type reactivity to human trophoblast being deleterious [4] .
In humans, placental and decidual tissues from normal pregnancies express an array of pro-and anti-inflammatory cytokines [5, 6] . This implies that a potent anti-inflammatory cytokine is produced locally to control fetal-ablating immune responses. The debate on the role of Th2 cytokines in human pregnancy may focus on interleukin 10 (IL10). IL10 can be produced by Th1 and Th2 cells and by non-T cells; therefore, it does not fit the classic Th2 cytokine profile. A major role of IL10 is the down-regulation of chemokine and cytokine production by Th1 cells and macrophages [7, 8] . When stimulated with trophoblast antigens, peripheral blood mononuclear cells (PBMCs) from women with a history of successful pregnancies secrete IL10 [9] . The stimulation of PBMCs with autologous placental cells results in the production of Th2 cytokines by women in labor and of Th1 cytokines by patients with spontaneous miscarriage [10] . Higher serum levels of IL10 were detected in women having normal delivery than in patients with recurrent PL (RPL) at the time of abortion, and higher concentrations of tumor necrosis factor a are detected in women with RPL than in women with successful pregnancy [11] . Furthermore, several studies [12] [13] [14] have confirmed that cytotrophoblasts and decidual T cells from normal pregnancies expressed IL10 and participate in Th2 predominance at the fetomaternal interface during the crucial stages of early pregnancy and the peri-implantation period. Recently, Blois S et al. [15] showed that treatment with recombinant galectin-1 (official symbol LGALS1, lectin, galactose binding, soluble 1), an immunoregulatory glycanbinding protein, prevented fetal loss and restored tolerance through multiple mechanisms, including the induction of uterine tolerogenic dendritic cells, which in turn promoted an increase in IL10-secreting regulatory T cells in vivo. Protective effects of galectin-1 were abrogated in mice deficient in IL10. IL10 down-regulation may thus be associated with susceptibility to immune-mediated PL, which mainly occurs during the early phase of intended pregnancies.
Pregnancy loss is a well-established complication of several thrombophilic disorders [16] [17] [18] . Ultrasonography has shown that the arterial signal in the yolk sac circulation disappears and that the umbilicoplacental circulation increases between the beginning of the eighth and 10th wk of gestation. The placenta replaces the yolk sac as an essential source of blood supply to the embryo at that time [19] . Maternal hemostatic defects are thus unlikely to have a deleterious role before this crucial period. In the Nîmes Obstetricians and Haematologists Study, Lissalde-Lavigne et al. [20] showed that factor V Leiden (F5 NM_000130.3:c.1601G.A) and factor II G20210A (F2 AF478696.1:g.21538G.A) mutations, known risk factors for thrombosis, were independent risk factors for miscarriages only from the 10th wk of gestation onward. Tissue factor (TF), the most important factor in the initiation of coagulation pathways, has a role in a number of pathological conditions associated with hypercoagulability and thrombogenesis [21, 22] . Furthermore, studies [13, 23] have shown that TF and IL10 are coexpressed by trophoblast cells. Because IL10 down-regulates TF expression [24] , we hypothized that this cytokine might have a physiological antithrombotic effect in the form of a defect in IL10 production, inducing placental vascular insufficiency and pregnancy failure. We previously showed that the risk of venous thrombosis [25] is modulated by the IL10 promoter polymorphisms IL10 X78437.2:g.8134CA [26] and IL10 X78437.2:g.8134CA [23] .
To evaluate the down-regulation of IL10 as a risk factor for placental hypercoagulability leading to its functional failure consequently to PL, we assessed the prevalence of IL10-related haplotypes among women with PL occurring before and after 10 wk of amenorrhoea. IL10 polymorphisms have been previously found to be associated with placenta failure [26] .
Evidence correlates IL10 gene promoter alleles with IL10 cell production and disease susceptibility, clinical features, and outcomes [27] . Characterization of the promoter and 5 0 flanking region of IL10 demonstrated the presence of positive and negative regulatory segments, single-nucleotide polymorphisms (SNPs), and polymorphic dinucleotide repeat elements [28] [29] [30] .
The number of tandem repeats localized in the promoter has been shown to influence the transcription rate by direct interaction with transcription factors [31] . Kube et al. [32] reported that the sequence located À1100 to À900 bp upstream of the transcription initiation site, including microsatellite IL10 X78437.2:g.8134CA(14_29), regulates IL10 expression. Furthermore, previous data [31] showed that cells carrying the longest IL10 X78437.2:g.8134CA(14_29) allele (.26 CA repeats) produced the highest amount of IL10 on induction with lipopolysaccharide (LPS), whereas the lowest production was observed in cells carrying the shortest IL10 X78437.2:g.8134CA(14_29) microsatellite [31] . Based on these and other findings [21] , it is tempting to speculate that short IL10 X78437.2:g.8134CA(14_29) alleles might be responsible for low IL10 production and may predispose to PL during the initial weeks of pregnancy (embryonic loss).
Microsatellites are considered biallelic polymorphisms, which facilitates study of the distribution of their alleles in haplotypes. We defined a short allele and a long allele for each microsatellite: 14_25 and 26_29 were the short and long alleles, respectively, of the X78437.2:g.8134CA(11_29) microsatellite, and 11_13 and 14_15 were the short and long alleles, respectively, of the X78437.2:g.5325CA(11_15) microsatellite.
IL10 down-regulation could increase the risk of PL, which may differ before and after the 10th wk of gestation. This study investigated correlations of the following IL10 promoter polymorphisms and their haplotypes with early and late PL: two SNPs rs1800871 and rs1800972 [29] and two polymorphic CA repeat microsatellites IL10 X78437.2:g.5325CA(11_15) and IL10 X78437.2:g.8134CA(14_29) [33, 34] .
MATERIALS AND METHODS

Patients
Patients were referred to the outpatient department of gynecology and obstetrics or to the hematology laboratory, University Hospital of Nîmes, between December 1997 and July 2002 for unexplained PL and relevant investigations. All PLs were documented. A complete clinical summary with emphasis on personal history for thromboembolic disease and previous PLs was obtained from all subjects by senior hematologists. Transvaginal ultrasonography was performed to confirm spontaneous abortion.
The inclusion criterion was primary (childless women) PL during natural pregnancies with no underlying classic risk factor. Risk factors had been previously excluded according to an invariable protocol proposed by the medical staff of the department of gynecology and obstetrics. Screens included infectious diseases during pregnancy (systematic human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and Chlamydia trachomatis serologies and toxoplasmosis serology), uterine anatomical abnormalities (hysterosalpingoscopy), diabetes mellitus, thyroid dysfunction, hyperprolactinaemia before luteal-phase defects (a normal luteal phase of !12 days and plasma progesterone level .25 ng/ml), erythroblastosis fetalis, Rh disease, immune thrombocytopenic purpura, and fetomaternal alloimmune thrombocytopenia. Any data missing from this protocol led to exclusion of the patient from the study. Any abnormality identified led to definition of the PL as explained.
Exclusion criteria included the following: 1) Women with previous superficial or deep vein thrombosis were excluded, as many of these had already been investigated for thrombophilia before the study, leading to treatment (including heparin and low-dose or high-dose aspirin) during pregnancy that interfered with the hemostatic system and possibly with the immune response. 2) Also excluded were women with preeclampsia, defined as gravidic hypertension (systolic blood pressure [BP] .140 mm Hg, diastolic BP .90 mm Hg, a rise in systolic BP .30 mm Hg, or a rise in diastolic BP .15 mm on at least two measurements that were 6 h apart) after 20 wk associated with significant proteinuria (.300 mg/24 h). 3) Women with abnormal maternal karyotype were excluded. 4) Also excluded were women of nonwhite race/ethnicity, which may have introduced consistent confounding heterogeneities in the local frequencies of the polymorphisms under focus.
The study was approved by the local ethics committee. After informed consent was obtained, 465 patients were recruited between December 1997 and July 2002.
Study Protocol
Basic biologic parameters. All women were subjected to blood analyses for classic pregnancy wastage-associated markers of dysimmunity as previously described [35] (antinuclear antibodies, antithyroid antibodies, antiphospholipid antibodies, lupus anticoagulant, anticardiolipin, anti-b2 glycoprotein I, antiannexin V IgG, and IgM autoantibodies). Samples were collected at least 3 mo after the last PL.
IL10 polymorphism analysis. Genomic DNA was extracted from whole blood by sodium chloride using a method described elsewhere [36] . Positive controls and IL10 promoter polymorphism alleles were determined by PCR. The PCR conditions were previously described by Cochery-Nouvellon et al. [25] . Terminology for microsatellites and SNP alleles is based on the international nomenclature (http://www.hgvs.org/).
Direct DNA sequencing of IL10 promoter (positive controls). To characterize DNA used as positive controls (described herein), we amplified and sequenced three regions of the IL10 promoter. The first region contained the two SNPs. The two other regions contained the X78437.2g.5325CA(11_15) or X78437.2:g.8134CA(14_29) microsatellite.
The following primers were used: 5 0 -aatccaagacaacactactaagg-3 0 (sense) and 5 0 -ttccattttactttccagaga-3 0 (antisense) for the SNPs, 5 0 -agatcttgtcaactgtagaatgc-3 0 (sense) and 5 0 -ggtaaagtccaaaggtttaa-3 0 (antisense) for X78437.2g.5325CA(11_15), and 5 0 -ttccccaggtagagca-3 0 (sense) and 5 0 -ggctggagtctaaagtttaa-3 0 (antisense) for X78437.2:g.8134CA(14_29). Polymerase chain reaction was performed with a total volume of 50 ll and 100 ng of genomic DNA. Final concentrations were 50 mM Tris HCl (pH 8.8), 25 mM KCl, 125 lM each deoxynucleotide triphosphate (dNTP) (PharmaciaAmersham), 30 pmol of primers, MgCl 2 at optimal concentration (i.e., 1.5 mM for X78437.2g.5325CA(11_15) and X78437.2:g.8134CA(14_29) or 2.5 mM for the SNPs), and 1 U of Taq polymerase (Invitrogen). All PCRs were performed on a 9700 Applied Biosystems thermocycler. After an initial melting time at 928C for 3 min, the following 35 cycles were used: 948C for 30 sec, 558C for 40 sec, and 728C for 40 sec, each followed by 728C for 7 min. DNA was sequenced in both directions using the ABI PRISM Dye Terminator Cycle Sequencing Kit on an ABI Prism 377 ABI sequencer (both from Applied Biosystems). The sequencing gel used was the Long Ranger gel (FMC Corporation).
Analysis of rs1800872 and rs1800871 by allele-specific PCR amplification. Two PCRs were performed for each SNP. The PCRs were performed with a total volume of 50 ll and 100 ng of sample genomic DNA. Final concentrations were 50 mM Tris HCl (pH 8.8), 25 mM KCl, 125 lM each dNTP, 1.5 mM MgCl 2 , 30 pmol of consensus primer and specific primers, and 1 U of Taq polymerase. The following cycles were used: 35 cycles of 948C for 30 sec, 548C for 40 sec (rs1800872) or 618C for 40 sec (rs1800871), and 728C for 40 sec, each followed by 728C for 7 min. The PCR products and 50-bp DNA Ladder (Invitrogen) were loaded for migration in a 2% agarose gel stained with ethidium bromide and then visualized under UV light. Quality control for the DNA amplification was performed using the F9 gene as an internal control as described previously [37] .
IL10 microsatellite fragment length analysis. The regions of the IL10 promoter containing X78437.2g.5325CA(11_15) and X78437.2: g.8134CA(14_29) were amplified by PCR. Sense primers were 5 0 labeled with 6-FAM fluorophore (Applied Biosystems). The PCR was performed with a total volume of 15 ll and 50 ng of sample genomic DNA. Final concentrations were 50 mM Tris HCl (pH 8.8), 25 mM KCl, 100 lM each dNTP, 15 pmol of primers, 1.5 mM MgCl 2 , and 0.25 U of Taq polymerase. After an initial melting time at 928C for 3 min, the following 30 cycles were used: 928C for 30 sec, 658C for 40 sec, and 728C for 40 sec, each followed by 728C for 7 min. Two microliters of 1:20 dilution of PCR product was mixed with 5 ll of formamide (95%) and loading buffer (5% blue dextran and 25 mM edetic acid [EDTA] ) that contained 0.5 ll of ROX-350 internal size standard (Applied Biosystems). After a denaturation step (958C for 5 min), 1.5 ll of this mixture was run onto a 12-cm-long 5% acrylamide Long Ranger gel with 13 Tris-borate-EDTA buffer. Electrophoresis was performed on the ABI Prism 377 at 1600 V for 1 h. The relationship between CA repeats and fragment length analysis of IL10 microsatellites was determined using sequenced positive controls. The fragment length analysis was automatically determined using Genescan 3.1 and Genotyper software (Applied Biosystems).
Linkage disequilibrium analysis and haplotype reconstruction. Linkage disequilibrium analysis was performed using Haploview 3.31 [38] . Haplotype reconstruction was performed using PHASE 2.1 [39] .
Statistical Analysis
The question being the correlation of the polymorphism under study with the clinical timing of PL, the 465 patients were classified in two groups based on the occurrence of PL (expressed in weeks of amenorrhea). The early group included 342 patients who experienced PL before 10 wk of amenorrhea (embryonic losses). The late group included 123 patients who experienced PL from the 10th wk of amenorrhea onward (fetal losses).
We performed a chi-square test to analyze Hardy-Weinberg equilibrium. Univariate analysis was performed to compare biologic parameters, allelic frequencies, and haplotype prevalences between the 2 patient groups. Allelic frequencies were calculated in the 2 groups. Chi-square test, Fisher exact test, and Student t-test were used to compare allelic frequencies, haplotypes prevalences, and biologic parameters between the groups. Late PL was considered the reference. We performed multivariate logistic regression analysis on alleles, haplotypes, and haplotype pairs to describe independent risk factors for early PL. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each variable. Because of multiple testing, P , 0.01 was considered statistically significant. Statistical computations were performed using SAS version 8.0 software (SAS Institute).
RESULTS
Basic Biologic Parameters
The mean age was not significantly different between the early group and the late group (mean 6 SD age, 32.3 6 4.7 and 32.9 6 4.69, respectively; P ¼ 0.8). Among 342 childless women with unexplained embryonic loss, 26 had experienced one loss, 184 two losses, and 132 three or more losses. Among 123 childless women with unexplained fetal loss, 22 had experienced one loss, 65 two losses, and 36 three or more losses.
All women were subjected to blood analyses for classic pregnancy wastage-associated autoantibodies. The frequency of any positive markers was not statistically different between the early group and the late group (data not shown).
IL10 Allele Polymorphism Analysis
In both groups, the polymorphisms rs1800871, rs1800872, I L 1 0 X 7 8 4 3 7 . 2 : g . 5 3 2 5 C A ( 1 1 _ 1 5 ) , a n d I L 1 0 X78437.2:g8134CA(14_29) were distributed according to Hardy-Weinberg equilibrium. High linkage disequilibrium was observed between the two SNPs rs1800872 and rs1800871, while it was lower between the other two polymorphisms (Fig. 1) .
Alleles A and T of the SNPs rs1800872 and rs180087, respectively, were more frequent in the early group than in the late group (0.32 and 0.32 vs. 0.15 and 0.16) (Table 1) . Furthermore, allele T of rs1800871 and allele A of rs1800872 were highly associated with early features of PL (OR, 3.083; 95% CI, 1.984-4.792; and OR, 3.013; 95% CI, 1.924-4.719; P , 0.0001 for both) ( Table 2) . 
Haplotype Analysis
Combinations of the four polymorphisms in the population allowed the observation of eight haplotypes (Table 3) . Haplotype rs1800872A/rs1800871T/X78437.2:g.8134CA(14_25)/ X78437.2:g.5325CA(11_13) was more prevalent in women with early PL (27.34% vs. 11.38%, P , 0.0001) and was significantly associated with this phenotype (OR, 2.92; 95% CI, 1.910-4.494; P , 0.0001) ( Table 4) .
Moreover, haplot ype rs1800872A/rs1800871T/ X78437.2:g.8134CA(14_25)/X78437.2:g.5325CA(11_13) was associated with early PL in a dose-dependent manner. The haplotype pair that contained one copy of rs1800872A/ r s 1 8 0 0 8 7 1 T / X 7 8 4 3 7 . 2 : g . 8 1 3 4 C A ( 1 4 _ 2 5 ) / X78437.2:g.5325CA(11_13) was associated with an OR of 5.677 (95% CI, 3.372-9.458; P , 0.0001), while the haplotype pair that contained two copies was associated with an OR of 8.061 (95% CI, 2.409-26.567; P ¼ 0.0007). When we combined the alleles of the SNPs rs1800872 and rs1800871 without considering those of microsatellites, women carrying the combination of A and T alleles had a 3.6-fold increased risk of early PL (OR, 3.612; 95% CI, 2.218-5.882). This proves that the association of the rs1800872A/rs1800871T/ X78437.2:g.8134CA(14_25)/X78437.2:g.5325CA(11_13) haplotype with early PL results from the A-T combination.
DISCUSSION
The objective of this study was to determine if IL10 downregulation associated with IL10 gene promoter polymorphisms correlates in women having PL with early embryonic (,10 wk of gestation) events or with fetal (late) events. The rationale is that IL10 may predispose to early PL if its main clinically relevant role is to induce maternal immunologic tolerance toward the placental unit or may predispose to later losses if its main role is to preserve a hemostatic balance allowing normal placental function.
The physiological significance of IL10 in pregnancy has been examined in animal models. IL10-null (Il10 À/À ) mice were housed with proven fertile IL10-null males (Il10 À/À ) for syngeneic pregnancy (major histocompatibility complex identical between mice and males) or allogeneic pregnancy (major histocompatibility complex disparate between mice and males) [40, 41] ; in the absence of both maternal and fetal IL10, placental differentiation was enhanced, and the success of pregnancy was not impeded. Adult mice gestated in an IL10-deficient uterus were smaller and exhibited altered body morphometry [41] . These studies were performed under pathogen-free conditions. Robertson et al. [42] examined the effect of IL10 deficiency on susceptibility to LPS-induced fetal resorption; increased fetal resorption at implantation sites and fewer viable fetuses were observed in IL10-deficient mice after LPS administration. The authors linked IL10 genetic deficiency to greater susceptibility to abortion and to fetal growth restriction in response to an inflammatory insult (e.g., the failure of very low doses of LPS to affect wild-type mice, supporting a protective effect of IL10).
Findings in human pregnancy failure indicate that successful pregnancy occurs in a Th2-biased setting, while Th1-type immunity may lead to pregnancy failure [43] . Th2 immunity induces maternal immunologic tolerance and allows implantation during the first weeks of amenorrhea and maintenance of the fetal semiallograft. Th2 factors responsible for immunosuppression include IL10 [11] .
More recent case-control, cohort, and cross-sectional investigations in women with poor pregnancy outcomes have shown that hypercoagulable disorders that promote thrombosis may increase susceptibility to fetal loss [17] . A large casecontrol study [20] on first pregnancies demonstrated that some constitutional risk factors for venous thrombosis are associated with greater risk of PL from the 10th wk onward in women of white race/ethnicity. Antiphospholipid antibodies, which are acquired risk factors for venous thrombosis, also predispose to PL, as evidenced in the clinical definition of the so-called antiphospholipid syndrome (APS). There are specific peculiarities of APS. Its implication in PL is traditionally presumed to be due to ''intraplacental thromboses.'' However, findings in humans have shown that thrombotic events cannot account for all of the histopathologic findings in placentae from women with APS [44] . It as been shown that anti-b2 glycoprotein I antibodies, the most clinically relevant antiphospholipid antibodies, bind to trophoblast monolayers [45] and induce expression in cell surface-altered molecules. The consequent trophoblast invasion alteration is associated with early PL [46] . Results of twin and family studies suggest that up to 75% of IL10 production variability is due to genetic factors [47] . It has also been demonstrated that most IL10 production is controlled at the transcription level and that some variability can be accounted for by genetic polymorphisms of the promoter gene [31, 47, 48] . This led us to evaluate the allele frequencies of rs1800871T and rs1800872A polymorphisms, previously linked to low IL10 production and to time-related PL [26, 48] . However, we have no specific individual data linking our studied polymorphisms with IL10 production in patients and controls.
Among women with PL, our study indicates that the rs1800872A/rs1800871T/X78437.2:g.8134CA(14_25)/ X78437.2:g.5325CA(11_13) haplotype is an independent risk factor for early unexplained PL. Our results also show that homozygosity for this haplotype is associated with the highest clinical risk among all pairs of haplotypes and represents a dose-dependent relationship. Furthermore, the major contribution of the two alleles rs1800872A and rs1800871T to the risk of early PL is confirmed. To our knowledge, this is the first correlation of this haplotype with PL occurring before 10 wk of gestation. The number of patients in our study per genotype was sufficient to demonstrate statistical significance. The rs1800872A and rs1800871T alleles were previously found to be associated with low production of IL10 [29, 48] . This may provide a molecular explanation for their role during early pregnancy. Down-regulation of IL10 could affect the maternal Th2 immune environment systemically and locally at the fetomaternal interface, with decidual IL10 expression also being affected.
It has been previously shown that immunologic maternal modifications during pregnancy are systemic but also occur at the fetomaternal interface, where extravillous trophoblasts and Th2 cells produce IL10 [13] . IL10 in immature dendritic cells in early human pregnancy decidua induces a state of alloantigen-specific anergy in CD4 þ T cells [41] . Recently, Blois et al. [15] showed that galectin-1, an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance, but effects were abrogated in mice deficient in IL10. Kovats et al. [49] demonstrated that HLA-G, a nonclassic class I human leukocyte antigen, is expressed mainly in the placenta. The recognition of soluble HLA-G protein by PBMCs or decidual tissue shifts the balance of Th1 and Th2 cytokines to Th2 polarization and induces IL10 secretion [50] . Polymorphisms in the IL10 gene promoter may thus have an effect on the quality of maternal tolerance to the embryo semiallograft, with early pregnancies being more exposed to immune rejection-related cytotoxic lethal lesions.
Our data suggest that IL10 promoter polymorphisms among women with PL may be associated with susceptibility to immune-mediated PL, mainly during the early embryonic phase of intended pregnancies. Because IL10 is secreted by trophoblasts that are encoded by maternal and paternal genes, further studies are warranted to determine the role of paternal IL10 polymorphisms to define (beyond women at risk) couples at risk for early PL.
